Prevalence of fecal carriage of ESBL-producing Enterobacteriaceae in hospitalized and ambulatory patients during two non-outbreak periods

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 26, Issue 1, 2007, Pages 77-78

  Castillo Garcia F J ^a   Seral Garcia C ^a   De La Gandara, M P ^a   Millan Lou M I ^a   Pitart Ferre C ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CLAVULANIC ACID; EXTENDED SPECTRUM BETA LACTAMASE;

AMBULATORY CARE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM ISOLATION; CAMPYLOBACTER; CHI SQUARE TEST; CONTROLLED STUDY; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; ENTEROBACTERIACEAE; ENZYME SYNTHESIS; ESCHERICHIA COLI; FECES ANALYSIS; FECES CULTURE; FECES MICROFLORA; HOSPITAL INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; NONHUMAN; OUTPATIENT; PREVALENCE; PRIORITY JOURNAL; PROTEUS MIRABILIS; PROTEUS VULGARIS; SALMONELLA ENTERICA; SALMONELLA VIRCHOW; STATISTICAL SIGNIFICANCE;

BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARRIER STATE; CROSS-SECTIONAL STUDIES; DISEASE OUTBREAKS; ENTEROBACTERIACEAE; FECES; HUMANS; INPATIENTS; MICROBIAL SENSITIVITY TESTS; OUTPATIENTS; PLASMIDS; PREVALENCE; SPAIN;

EID: 33846152652     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-006-0242-8     Document Type: Article

References (10)

1. Tzouvelekis LS, Tzelepi E, Tassios PT, Legakis NJ (2000) CTXM-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int J Antimicrob Agents 14:137-142
2. Rodriguez-Baño J, Navarro MD, Romero L, Martinez-Martinez L, Muniain MA, Perea EJ, Perez-Cano R, Pascual A (2004) Epidemiology and clinical features of infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in nonhospitalized patients. J Clin Microbiol 42:1089-1094
3. De Champs C, Sauvant MP, Chanal C, Sirot D, Gazuy N, Malhuret R, Baguet JC, Sirot J (1989) Prospective survey of colonization and infection caused by expanded-spectrum beta-lactamase-producing members of the family Enterobacteriaceae in an intensive care unit. J Clin Microbiol 27:2887-2890
4. Peña C, Pujol M, Ardanuy C, Ricart A, Pallares R, Linares J, Ariza J, Gudiol F (1998) Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 42:53-58
5. Valverde A, Coque TM, Sanchez-Moreno MP, Rollan A, Baquero F, Canton R (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae during nonoutbreak situations in Spain. J Clin Microbiol 42:4769-4775
6. Mirelis B, Navarro F, Miro E, Mesa RJ, Coll P, Prats G (2003) Community transmission of extended-spectrum beta-lactamase. Emerg Infect Dis 9:1024-1025
7. Murray P, Baron E, Pfaller M, Tenover F, Yolken R (eds) (1999) Manual of clinical microbiology, 7th edn. American Society for Microbiology, Washington, DC
8. Legrand P, Fournier G, Bure A, Jarlier V, Nicolas MH, Decre D, Duval J, Philippon A (1989) Detection of extended broadspectrum beta-lactamases in Enterobacteriaceae in four French hospitals. Eur J Clin Microbiol Infect Dis 8:527-529
9. National Committee for Clinical Laboratory Standards (2000) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A5 and informational supplement M100-S10. National Committee for Clinical Laboratory Standards, Wayne, PA
10. Castillo J, Seral C, Millán MI, Pardos M (2006) Extended-spectrum beta-lactamase-producing Enterobacteriaceae in both hospitalized and nonhospitalized patients in Zaragoza (Spain) during 2001-2004. Enferm Infecc Microbiol Clin 24:592-593